Group structure
6 companies in 3 countries
Malaysia1
United Kingdom1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 386
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| bilastina | Bilastine | Brazil | Authorised | 2026 |
| MEMANTINE HYDROCHLORIDE2mg/ml · Solution | Memantine | United States | Marketed | 2015 |
| ABSTEN S | Mazindol | Brazil | Cancelled | 1996 |
| ACCERA | Tartarato brimonidina | Brazil | Cancelled | 2011 |
| ACEBROFILINA | Acebrofilina | Brazil | Cancelled | 2004 |
| ACETATO DE CLORMADINONA+ETINILESTRADIOL | Clormadinona, Ethinyl estradiol | Brazil | Cancelled | 2013 |
| ACETATO DE CLOSTEBOL + SULFATO DE NEOMICINA | Clostebol, Neomycin | Brazil | Cancelled | 2007 |
| ACETATO DE CLOSTEBOL + SULFATO DE NEOMICINA | Clostebol, Neomycin | Brazil | Cancelled | 2007 |
| ACETILCISTEINA | Acetylcysteine | Brazil | Cancelled | 2005 |
| Acetofen | Paracetamol | Brazil | Cancelled | 1996 |
| ACICLOVIR | Aciclovir | Brazil | Cancelled | 2001 |
| Acido Mefenamico | Mefenamic acid | Brazil | Cancelled | 2008 |
| ACTIVELLE | Estradiol, Norethindrone | Brazil | Cancelled | 2001 |
| ADAPALENO | Adapalene | Brazil | Cancelled | 2007 |
| ADAPEL | Adapalene | Brazil | Cancelled | 2008 |
| AIXA | Clormadinona, Ethinyl estradiol | Brazil | Cancelled | 2013 |
| ALBENDAZOL | Albendazole | Brazil | Cancelled | 2005 |
| ALBENDAZOL | Albendazole | Brazil | Cancelled | 2005 |
| ALBENDAZOL | Albendazole | Brazil | Cancelled | 2005 |
| ALEDEX | Dexclorfeniramina | Brazil | Cancelled | 2008 |
| ALENTHUS XR | Venlafaxine | Brazil | Cancelled | 2007 |
| ALOPURINOL | Allopurinol | Brazil | Cancelled | 2008 |
| Alprazolam | Alprazolam | Brazil | Cancelled | 2008 |
| ALZEPINOL | Oxcarbazepine | Brazil | Cancelled | 2007 |
| AMBRA SINTO T | Tetracycline | Brazil | Cancelled | 2003 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 385 | 1 | 384 | CompaniesAll medicines |
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Malaysia, United Kingdom
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Report an error or request removalCorrections from the company itself are welcome.
Keep Medley’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.